Frederick C. de Beer, M.D.

Position(s):

Dean/Vice Pres Clinical Academic Affairs

Affiliation(s):

Other Affiliation(s):

MD/PhD Program Mentor

CVRC - Core Faculty

Inflammation and Lipoprotein Metabolism Research Group

Microbiology, Immunology & Molecular Genetics - Adjunct Faculty

Nutritional Sciences Graduate Faculty

pharmns-Joint Faculty

PubMed Publications:

Thompson, J.C.;Wilson, P.G.;Shridas, P.;Ji, A.;Beer, M.;Beer, F.C.;Webb, N.R.;Tannock, L.R. "Serum amyloid A3 is pro-atherogenic." Atherosclerosis 268, (2018): 32-35. [PubMed Link] | [ Full text ]
Tannock, L.R.;De Beer, M.C.;Ji, A.;Shridas, P.;Noffsinger, V.P.;Hartigh, L.;Chait, A.;Beer, F.C.;Webb, N.R. "Serum amyloid A3 is a high density lipoprotein-associated acute-phase protein." Journal of lipid research 59, 2 (2018): 339-347. [PubMed Link] | [ Full text ]
Kim, M.H.;De Beer, M.C.;Wroblewski, J.M.;Charnigo, R.J.;Ji, A.;Webb, N.R.;Beer, F.C.;Westhuyzen, D.R. "Impact of individual acute phase serum amyloid A isoforms on HDL metabolism in mice." Journal of lipid research 57, 6 (2016): 969-79. [PubMed Link] | [ Full text ]